Mesa Laboratories stock has results scheduled for November 9, 2026

Published on 10/15/2026 at 20:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-quarter revenue reached USD 60.14 million, up 1.00 percent year over year. Mesa Laboratories stock costs EUR 114.00 on October 15, 2026.

Results date and valuation

Mesa Laboratories will report second-quarter fiscal year 2027 results on November 9, 2026.
First-quarter fiscal year 2027 revenue reached USD 60.14 million, up 1.00 percent year over year.
Mesa Laboratories stock costs EUR 114.00 at Lang & Schwarz on October 15, 2026 at 8:32 p.m. CEST.
Mesa Laboratories had a market capitalization of USD 716.4 million and a P/E ratio of 152.04 as of October 15, 2026.

MLAB, US59064R1095, Illustration mit AI erstellt.

Mesa Laboratories has its next results scheduled for November 9, 2026, when it will provide fiscal year 2027 guidance, according to GlobeNewswire. Mesa Laboratories stock was trading at EUR 114.00 at Lang & Schwarz on October 15, 2026 at 8:32 p.m. CEST.

Fiscal 2027 guidance arrives November 9

The date matters because Mesa Laboratories plans to publish second-quarter fiscal year 2027 results and company-level fiscal year 2027 guidance together. The company said the guidance will reflect its savings plan and the expected decrease in Clinical Genomics revenue, according to GlobeNewswire on October 13, 2026.

Revenue edges higher in first quarter

Mesa Laboratories reported USD 60.14 million in first-quarter fiscal year 2027 revenue, up 1.00 percent from the year-ago quarter. Earnings came to USD 2.68 per share in the same period, according to MarketBeat on October 3, 2026. The modest revenue increase leaves the November release as the next dated test for the company's profitability plan.

Price stays below yearly high

The primary-market quote was USD 128.02 on Nasdaq at 2:36 p.m. ET on October 15, 2026. That level stood USD 16.33, or 11.32 percent, below the 52-week high of USD 144.35 and above the 52-week low of USD 69.51. The current volume was 67,827 shares against an average volume of 137,585 shares.

Valuation and upcoming date

Mesa Laboratories had a market capitalization of USD 716.4 million, a P/E ratio of 152.04 and a dividend yield of 0.01 percent as of October 15, 2026. The valuation figures place the November 9 reporting date at the center of the near-term calendar, particularly because guidance is due with the results.

Comparison with peers

Mesa Laboratories (Nasdaq, USD): P/E 152.04, market capitalization USD 716.4 million
Mettler-Toledo International (NYSE, USD): plus 2.67 percent, P/E 37.15, market capitalization USD 33.1 billion
Bio-Rad Laboratories (NYSE, USD): plus 1.45 percent, P/E 44.57, market capitalization USD 9.9 billion

Euro quote after hours

For investors in Germany, the euro quotation puts the US-listed company at EUR 114.00 at Lang & Schwarz on October 15, 2026 at 8:32 p.m. CEST. The Nasdaq quote was still in its regular session when the primary-market figures were captured at 2:36 p.m. ET.

The further course of trading is shown by the continuously updated real-time quote of Mesa Laboratories stock.